{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:51:13Z","timestamp":1790034673422,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bcp.2016.06.020","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T08:56:18Z","timestamp":1467536178000},"page":"11-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases"],"prefix":"10.1016","volume":"116","author":[{"given":"Ivana","family":"Strazic-Geljic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Guberovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanka","family":"Didak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidy","family":"Schmid-Antomarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Schmid-Alliana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Boukhechba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Bouler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Scimeca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Verron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.06.020_b0005","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.drudis.2014.04.004","article-title":"Therapeutic strategies for treating osteolytic bone metastases","volume":"19","author":"Verron","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2016.06.020_b0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2016.06.020_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"12","author":"Chen","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/bcr2835","article-title":"Therapeutic targets for bone metastases in breast cancer","volume":"13","author":"Clezardin","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bcp.2016.06.020_b0030","first-page":"341","article-title":"Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice","volume":"4","author":"Delea","year":"2006","journal-title":"J. Support. Oncol."},{"key":"10.1016\/j.bcp.2016.06.020_b0035","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.22991","article-title":"Pathologic fractures correlate with reduced survival in patients with malignant bone disease","volume":"110","author":"Saad","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2016.06.020_b0040","first-page":"144","article-title":"Mechanisms of bone metastasis","volume":"4","author":"Roodman","year":"2004","journal-title":"Discov. Med."},{"key":"10.1016\/j.bcp.2016.06.020_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/cbt.7.1.5163","article-title":"Biology of breast cancer bone metastasis","volume":"7","author":"Akhtari","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2016.06.020_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2010.08.004","article-title":"TGF-beta in cancer and bone: implications for treatment of bone metastases","volume":"48","author":"Juarez","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2016.06.020_b0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12307-011-0075-6","article-title":"TGF-beta in the bone microenvironment: role in breast cancer metastases","volume":"4","author":"Buijs","year":"2011","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.bcp.2016.06.020_b0060","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.2174\/138920111798808293","article-title":"Therapeutic strategies to target TGF-beta in the treatment of bone metastases","volume":"12","author":"Buijs","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bcp.2016.06.020_b0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10238-006-0117-4","article-title":"Stephen Paget and the \u2018seed and soil\u2019 theory of metastatic dissemination","volume":"6","author":"Ribatti","year":"2006","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bcp.2016.06.020_b0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bone.2010.07.015","article-title":"Advances in the biology of bone metastasis: how the skeleton affects tumor behavior","volume":"48","author":"Sterling","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2016.06.020_b0075","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11132","article-title":"Mechanisms of osteolytic bone metastases in breast carcinoma","volume":"97","author":"Kakonen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2016.06.020_b0080","doi-asserted-by":"crossref","first-page":"9656","DOI":"10.1073\/pnas.152324099","article-title":"Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover","volume":"99","author":"Street","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.06.020_b0085","doi-asserted-by":"crossref","DOI":"10.1172\/JCI82585","article-title":"Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair","author":"Hu","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2016.06.020_b0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijsu.2006.04.005","article-title":"Vascular endothelial growth factor augments the healing of demineralized bone matrix grafts","volume":"4","author":"Emad","year":"2006","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.bcp.2016.06.020_b0095","doi-asserted-by":"crossref","first-page":"11853","DOI":"10.1073\/pnas.1003317107","article-title":"Fgf-9 is required for angiogenesis and osteogenesis in long bone repair","volume":"107","author":"Behr","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.06.020_b0100","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.drudis.2012.06.007","article-title":"Gallium as a potential candidate for treatment of osteoporosis","volume":"17","author":"Verron","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2016.06.020_b0105","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4155\/fmc.12.69","article-title":"Gallium-containing anticancer compounds","volume":"4","author":"Chitambar","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bcp.2016.06.020_b0110","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1476-5381.2010.00665.x","article-title":"Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts","volume":"159","author":"Verron","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2016.06.020_b0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bcp.2011.12.015","article-title":"Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes","volume":"83","author":"Verron","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.06.020_b0120","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0031-6997(24)01383-8","article-title":"Mechanisms of therapeutic activity for gallium","volume":"50","author":"Bernstein","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2016.06.020_b0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1040-8428(01)00225-6","article-title":"Gallium in cancer treatment","volume":"42","author":"Collery","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bcp.2016.06.020_b0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1200\/JCO.1987.5.2.292","article-title":"Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases","volume":"5","author":"Warrell","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2016.06.020_b0135","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1680::AID-CNCR19>3.0.CO;2-W","article-title":"Gallium nitrate for the treatment of bone metastases","volume":"80","author":"Warrell","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2016.06.020_b0140","first-page":"887","article-title":"Gallium nitrate in prostatic cancer: evaluation of antitumor activity and effects on bone turnover","volume":"71","author":"Scher","year":"1987","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.bcp.2016.06.020_b0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bone.2008.03.026","article-title":"Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation","volume":"43","author":"Guo","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2016.06.020_b0150","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1359\/jbmr.070406","article-title":"Differential binding of poly(ADP-Ribose) polymerase-1 and JunD\/Fra2 accounts for RANKL-induced Tcirg1 gene expression during osteoclastogenesis","volume":"22","author":"Beranger","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0155","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1073\/pnas.98.3.992","article-title":"Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor beta growth arrest program","volume":"98","author":"Chen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.06.020_b0160","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1359\/jbmr.2001.16.8.1486","article-title":"A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro","volume":"16","author":"Yoneda","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0165","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbrc.2004.05.033","article-title":"Breast cancer cell line MDA-MB 231 exerts a potent and direct anti-apoptotic effect on mature osteoclasts","volume":"319","author":"Gallet","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2016.06.020_b0170","first-page":"3059","article-title":"Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites","volume":"51","author":"Powell","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0175","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00774-008-0857-1","article-title":"Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice","volume":"26","author":"Nakamura","year":"2008","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bcp.2016.06.020_b0180","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose","volume":"261","author":"Hauschka","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.06.020_b0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2016.06.020_b0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1024443303436","article-title":"Tumor necrosis factor-alpha induces interleukin-6 production via extracellular-regulated kinase 1 activation in breast cancer cells","volume":"80","author":"Suarez-Cuervo","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bcp.2016.06.020_b0195","first-page":"3821","article-title":"Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity","volume":"21","author":"Bachmeier","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1014993006190","article-title":"Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells","volume":"72","author":"Barrett","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bcp.2016.06.020_b0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jbmr.5650110111","article-title":"Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B","volume":"11","author":"Witty","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0210","first-page":"4028","article-title":"Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis","volume":"5","author":"Arnold","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0215","first-page":"4247","article-title":"Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy","volume":"24","author":"Rahko","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0220","first-page":"5386","article-title":"The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma","volume":"57","author":"Littlewood-Evans","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mvr.2007.03.004","article-title":"Roles for VEGF in the adult","volume":"74","author":"Maharaj","year":"2007","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0230","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1471-2164-11-229","article-title":"Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells","volume":"11","author":"Wilson","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bcp.2016.06.020_b0235","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cyto.2009.03.012","article-title":"Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis","volume":"46","author":"Costa","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2016.06.020_b0240","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ejca.2010.02.040","article-title":"Targeting the transforming growth factor-beta signalling pathway in metastatic cancer","volume":"46","author":"Korpal","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2016.06.020_b0245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/cr.2008.316","article-title":"Roles of TGFbeta in metastasis","volume":"19","author":"Padua","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0250","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.139","article-title":"Inhibition of TGF-beta signaling by 1D11 antibody treatment increases bone mass and quality in vivo","volume":"25","author":"Edwards","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0255","doi-asserted-by":"crossref","first-page":"24571","DOI":"10.1074\/jbc.M202561200","article-title":"Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways","volume":"277","author":"Kakonen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.06.020_b0260","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1158\/0008-5472.CAN-04-1844","article-title":"CXCR4 regulates growth of both primary and metastatic breast cancer","volume":"64","author":"Smith","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2016.06.020_b0265","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.06.020_b0270","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.actbio.2015.05.027","article-title":"Design and properties of novel gallium-doped injectable apatitic cements","volume":"24","author":"Mellier","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2016.06.020_b0275","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.drudis.2010.05.003","article-title":"Calcium phosphate biomaterials as bone drug delivery systems: a review","volume":"15","author":"Verron","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2016.06.020_b0280","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1016\/j.actbio.2012.06.022","article-title":"Controlling the biological function of calcium phosphate bone substitutes with drugs","volume":"8","author":"Verron","year":"2012","journal-title":"Acta Biomater."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216301654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216301654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T23:42:56Z","timestamp":1748994176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295216301654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":56,"alternative-id":["S0006295216301654"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.06.020","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}